Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pueraria Lobata Radix for Type 2 Diabetes Mellitus
NCT06494683Recruiting
- Sponsor
- Jiangxi University of Traditional Chinese Medicine
- Start
- Jul 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Pueraria lobata radix group with Placebo group (2 arms). Primary endpoint: Glycated Hemoglobin A1c at Week 12. Started Jul 2024; status: recruiting.
02
Drugs
puerariae lobatae radix
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06494683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06494683.